Clinical Trial Update: Haploid Allogeneic Transplant Using the CliniMACS System [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating haploid allogeneic transplantation using the CliniMACS System was terminated, with results posted in 2015 across several hem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• CliniMACS System

Snippet

Sponsor: Ginna Laport | Conditions: Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors, Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase | Phase 2 | Status: TERMINATED | Results posted: 2015-03-09